Flavanols and Cardiovascular Disease Prevention

Christian Heiss; Carl L. Keen; Malte Kelm


Eur Heart J. 2010;31(21):2583-2592. 

In This Article


While flavanols represent a promising class of food components that are associated with lower cardiovascular risk and can positively affect cardiovascular surrogate parameters in the short term, epidemiological studies are prone to confounders and no long-term randomized controlled dietary intervention trials with hard clinical endpoints are available to date. More clinical and experimental studies are needed before flavanols can be considered as a feasible therapeutic option in cardiovascular medicine.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: